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The Committee on Pediatric Obesity of the Korean Society of Pediatric Gastroenterology, Hepatology 
and Nutrition newly developed the first Korean Guideline on the Diagnosis and Treatment of Obesity in 
Children and Adolescents to deliver an evidence-based systematic approach to childhood obesity in South 
Korea. The following areas were systematically reviewed, especially on the basis of all available references 
published in South Korea and worldwide, and new guidelines were established in each area with the 
strength of recommendations based on the levels of evidence: (1) definition and diagnosis of overweight 
and obesity in children and adolescents; (2) principles of treatment of pediatric obesity; (3) behavioral 
interventions for children and adolescents with obesity, including diet, exercise, lifestyle, and mental 
health; (4) pharmacotherapy; and (5) bariatric surgery.
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Introduction 
The prevalence of childhood obesity is dramatically increasing in South Korea, which has 
been associated with changes in lifestyle, such as Westernized high-calorie, high-fat diet with 
sugar-sweetened beverages, sedentary lifestyles, and decreased physical activity.1) In a recent 
report, the prevalence of obesity in children aged below 6 years increased from 1.4% in 2008 to 
2.8% in 2015, and that in children and adolescents aged 7 to 18 years rapidly increased from 
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compass a total of eight topics within 5 different sections as follows: 
(1) Definition and diagnosis of overweight and obesity in children 
and adolescents
(2) Principles of the treatment of pediatric obesity
(3) Behavioral interventions for children and adolescents with 
obesity
• Diet
• Exercise
• Lifestyle
• Mental health
(4) Pharmacotherapy in children and adolescents with obesity
(5) Bariatric surgery in children and adolescents with obesity
Each TF working subgroup searched all references related to 
pediatric obesity in each assigned field through PubMed search 
using MeSH terms, as well as all available references published 
in South Korea using appropriate systematic search strategies. 
These references included randomized controlled trials (RCTs), 
observational studies (e.g., case-control studies, prospective and 
retrospective cohort studies, case series studies), meta-analyses, 
systematic reviews, and previous obesity guidelines or position 
papers or consensuses on both children and adults with obesity 
through the entire period using a last search date of September 30 
2018. Subsequently, each TF subgroup reviewed, analyzed, and 
summarized all related documents and references in each field. 
To establish a systematic evidence-based guideline, the strength 
of evidence and grade of recommendation were determined for each 
recommendation according to a previously adapted classification 
system for evidence-based guidelines (Table 1).3-5) The strength of 
evidence was classified from level I to level V based on the value of 
the evidence in the literature, including systematic review, meta-
analysis, and scientific papers: RCTs, well-designed trials, consensus 
studies, and opinions of research groups, respected authorities, and 
expert committees. Level I represents the strongest evidence. 
The grade of recommendation was determined according to the 
strength of evidence and importance of the recommendation. Le-
vels I to III evidence were decided to correspond to grades A to C of 
recommendations, which were regarded as highly recommended 
8.4% in 2008 to 14.3% in 2016.1) Accordingly, the prevalence of 
obesity-related physical, psychosocial, and metabolic complications, 
such as metabolic syndrome and nonalcoholic fatty liver disease 
(NAFLD), is also increasing in Korean children and adolescents.2)
Childhood obesity may persist lifelong if not treated properly; 
it can lead to adulthood obesity and a variety of metabolic and 
cardiovascular complications later in life. Thus, pediatric obesity is 
regarded as one of the priority health issues, and the treatment of 
childhood obesity and its complications may be one of the most 
effec tive strategies to reducing morbidities and mortalities and to 
saving hospital costs later in life.
Strict guidelines or consensus statements on the diagnosis and 
treatment of pediatric obesity have been published and updated in 
Western countries. However, to date, there are no evidence-based 
guidelines on pediatric obesity in Asia, including South Korea. 
Therefore, the Committee on Pediatric Obesity of the Korean Society 
of Pediatric Gastroenterology, Hepatology and Nutrition (KSPGHAN) 
developed an evidence-based guideline on the diagnosis and treat-
ment of obesity in children and adolescents, to deliver a systematic 
approach to childhood obesity in South Korea.
Materials and methods
To develop the first evidence-based clinical practice guideline on 
the diagnosis and treatment of obesity in children and adolescents in 
South Korea, the Committee on Pediatric Obesity of the KSPGHAN 
established a Guideline Task Force (TF) in March 2017. This TF 
was composed of pediatric gastroenterologists with an expertise 
in clinical nutrition, as well as pediatric neuropsychiatrists, clinical 
nutrition specialists, and exercise specialists. Experts from these 
areas were designated to each TF subgroup according to their 
professional specialty. 
A systematic protocol for the establishment of an evidence-based 
guideline for the diagnosis and treatment of obesity in children 
and adolescents was prepared and established through regular TF 
meetings. The basic format of the guideline was determined to en-
Table 1. The strength of evidence and the grade of recommendation in support of the recommendations formulated and established in the KSPGHAN 
clinical practice guideline on the diagnosis and treatment of pediatric obesity5)
Strength of evidence Grade of recommendation
I Grade A Strong evidence from one or more systematic review(s) of well-designed RCTs Highly recommended
II Grade B Strong evidence from one or more properly designed RCT(s) of appropriate size Recommended
III Grade C Evidence from well-designed clinical trials without randomization, comparative 
study in a single group, cohort study, time series study or matched case-
control studies
Recommended
IV Grade D Evidence from well-designed clinical trials, nonexperimental studies from one 
or more center or research group
The consensus route would 
have to be adopted
V Grade D Opinion of respected authorities, clinical evidence, descriptive studies, or 
reports of experts committees
The consensus route would 
have to be adopted
KSPGHAN, Korean Society of Pediatric Gastroenterology Hepatology and Nutrition; RCT, randomized controlled trial.
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or recommended, respectively. Levels IV and V recommendations 
for were basically regarded as grade D; the final grade was decided 
through voting consensus of the entire TF. A total of three face-
to-face meetings were held in Seoul and Jeju Island and 14 online 
video meetings to achieve consensus on all of the recommendations. 
All recommendations were voted on and accepted when 100% 
agreement was achieved.
1. Definition and diagnosis of overweight and obesity in children 
and adolescents 
1-1. We suggest to use the Korean National Growth Charts body 
mass index (BMI) percentile to diagnose overweight and obesity in 
children and adolescents over 2 years of age. (strength of evidence, 
level III; grade of recommendation, C)
1-2. We suggest to diagnose overweight when the BMI is above 
the 85th but less than the 95th percentile for age and sex, and 
obesity when the BMI is above the 95th percentile in children and 
adolescents >2 years of age. (strength of evidence, III; grade of 
recommendation, C)
1-3. We suggest that children <24 months of age be diagnosed as 
overweight if their weight for height is above the 95th percentile 
on the Korean National Growth Charts, which introduced the 
World Health Organization (WHO) growth standards in this age 
valid. (strength of evidence, V; grade of recommendation, C, based 
on committee voting)
1-4. We recommend to assess comorbidities: NAFLD, dyslipidemia, 
hypertension, prediabetes, type II diabetes mellitus (DM), polycystic 
ovary syndrome, obstructive sleep apnea, and psychosocial 
problems. (strength of evidence, V; grade of recommendation, A, 
based on committee voting)
1-1. We suggest to use the Korean National Growth Charts BMI 
percentile to diagnose overweight and obesity in children and 
adolescents over 2 years of age. (strength of evidence, level III; 
grade of recommendation, C)
The Korean National Growth BMI charts are accepted as valid for 
Korean children and adolescents over 2 years of age and provide 
a means for determining changes in pediatric obesity prevalence.6) 
The 2017 Korean National Growth Charts are recommended for 
the evaluation of body size and growth of Korean children and 
adolescents to use in practice and in the public health sector in South 
Korea.6)
A systematic review by the United States Preventive Services 
TF reported that the BMI of children and adolescents correlate 
well to the percentile of body fat.7) In 1990s, an expert committee 
recommended using BMI for screening overweight in children and 
adolescents.8) In the 2000 Centers for Disease Control (CDC) Growth 
Chart and 2011 United Kingdom (UK) Growth Chart (http://www.
rcpch.ac.uk/growthcharts), the BMI chart is available for children 
and adolescents aged 2 to 20 years.9) Meanwhile, a considerable 
proportion of boys and girls with relatively normal fat mass ap-
pear to be misclassified and may be at risk of being overweight 
based on the BMI criteria in a Korean study using the Korea 
National Health and Nutrition Examination Survey; their findings 
indicated that body fat mass and fat-free mass would be helpful 
for complementary assessment.10) Despite some limitations, BMI is 
currently the most reasonable method for diagnosing overweight 
and obesity in children over 2 years old.
1-2. We suggest to diagnose overweight when the BMI is above 
the 85th but lower than the 95th percentile for age and sex, and 
obesity when the BMI exceeds the 95th percentile in children 
and adolescents over 2 years of age. (strength of evidence, III; 
grade of recommendation, C)
1-3. We suggest that children <24 months of age be diagnosed as 
overweight if their weight for height is above the 95th percentile 
on the Korean National Growth Charts, which intro duced the 
WHO growth standards in this age group, as the Korean Society 
of Pediatrics has accepted this standard as valid. (strength of 
evidence, V; grade of recommendation, C, based on committee 
voting)
The Korean National Growth Chart recently revised the BMI 
cutoffs of obesity in children and adolescents. The criteria of obesity 
for children aged >2 years have changed from a BMI of ≥95th 
percentile for age and sex or BMI ≥25 kg/m2 to a BMI of ≥95th per-
centile for age and sex.6) When applying a new BMI cutoff and a 
recently developed Korean National Growth Chart, a study reported 
that the prevalence of obesity is 10.3% in South Korea.6) These cri-
teria, based on the BMI percentiles, are the same as those used in 
United States of America (US), based on the CDC growth chart, and 
in the UK (http://www.rcpch.ac.uk/growthcharts).9,11) We could not 
find any meta-analysis or systematic review to justify applying 
the adult standards of BMI ≥25 kg/m2 to children, regardless of 
risk evaluations of comorbidities. In children aged under 2 years, 
the criteria of overweight were changed from weight for age to 
weight for height in a recent 2017 Korean Growth Chart after the 
introduction of the WHO Child Growth Standards.12)
Data suggest that severely obese children and adolescents have a 
worse risk factor profile compared with less obese children. In a large 
cross-sectional and longitudinal study in the US, 59% of children 
with BMI≥99th percentile had at least 2 risk factors, whereas 39% 
of children with BMI ≥95th percentile had at least 2 risk factors.13) 
Consequently, expert committees in the US and Italy have suggested 
BMI≥99th percentile as severe obesity in older children.14,15) In 
another proposed US guideline, extreme or class 2 obesity in 
children is defined as a BMI exceeding 120% of the 95th percentile 
or >35 kg/m2, and class 3 obesity to be BMI exceeding 140% of the 
95th percentile or >40 kg/m2,11) 
WHO provides the values of BMI as ≥99th percentile and +3 
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standard deviations of z scores.16) The WHO definition for severe 
obesity differs between age groups. The 99th percentile identifies 
“obesity” in the younger age group (0–5 years) and “severe obesity” 
in the older age group (5–18 years). This approach takes into 
account the difference in growth process between younger and older 
children. Few data are available on the significance of the cutoffs for 
the upper end of the BMI in preschool-aged children. Moreover, the 
WHO cutoffs for severe obesity have not been assessed yet. 
The Korean Growth Chart also provides the curves of BMI ≥99th 
percentile and +3 standard deviations of z scores in its website 
(http://www.cdc.go.kr/).
1-4. We recommend to assess comorbidities: NAFLD, dyslipi-
demia, hypertension, prediabetes, type II DM, polycystic ovary 
syndrome, obstructive sleep apnea, and psychosocial problems. 
(strength of evidence, V; grade of recommendation, A, based on 
committee voting)
In obese children and adolescent's, the assessment for comor-
bidities is recommended (Fig. 1). Table 2 lists the suggested obesity-
related comorbidities and their corresponding screening tests.17-22)
2. Principles of the treatment of pediatric obesity
2-1. We recommend a treatment algorithm to help physicians 
determine the appropriate weight management stage for each 
patient, on the basis of his or her age, BMI percentile, and comor-
bidities. (strength of evidence, I; grade of recommendation, A) 
2-2. We recommend a family-based, comprehensive, multi-
disciplinary team approach to succeed in behavioral interventions 
(active vigorous physical activity and reduction of inactivity, 
accompanied with calorie-controlled diet) for the treatment of 
obesity in children. (strength of evidence, I; grade of recommen-
dation, A)
2-3. We recommend that pharmacotherapy and bariatric sur-
gery be considered only in patients with morbid obesity with 
major comorbidities after a formal program of intensive lifestyle 
modification has failed. (strength of evidence, V; grade of re-
commendation, A, based on committee voting)
2-1. Treatment algorithm to help physicians determine the ap-
propriate weight management stage for each patient, on the 
basis of his or her age, BMI percentile, and comorbidities 
(strength of evidence, I; grade of recommendation, A)
Behavioral interventions for lifestyle modification represent the 
key principle recommended for the treatment of overweight and 
obesity in children and adolescents. The following are the staged 
treatment strategies for pediatric obesity according to age and BMI 
percentile23):
1) Children aged 2–5 years
(1) BMI 85th–94th percentile (overweight)
The weight goal is weight maintenance until reaching a BMI 
below the 85th percentile or slowing of weight gain, as indicated by 
the downward deflection in the BMI curve.
(2) BMI 95th–98th percentile (obesity)
The weight goal is weight maintenance until reaching a BMI 
below the 85th percentile; however, if weight loss occurs with 
healthy, adequate-energy diet, it should not exceed 0.5 kg/mo. If 
greater weight loss is noted, monitor the patient for causes of ex-
cessive weight loss.
(3) BMI ≥99th percentile (severe obesity)
The weight goal is gradual weight loss not exceeding 0.5 kg/
mo. If greater weight loss occurs, monitor the patient for causes of 
excessive weight loss.
2) Children aged 6–11 years
(1) BMI 85th–94th percentile (overweight)
The weight goal is weight maintenance until reaching a BMI not 
exceeding the 85th percentile or slowing of weight gain, as indicated 
by the downward deflection in the BMI curve. 
(2) BMI 95th–98th percentile (obesity)
The weight goal is weight maintenance until reaching a BMI of 
below the 85th percentile or gradual weight loss of approximately 
0.5 kg/mo. If greater loss is noted, monitor the patient for causes of 
excessive weight loss. 
(3) BMI ≥99th percentile (severe obesity)
The weight goal is weight loss not exceeding the average of 0.9 
In children and adolescents with 
BMI ≥85th percentile 
• Through history takin 
• Physical Examination 
• Evaluation for comorbidities: 
NAFLD, dyslipidemia, hypertension, 
prediabetes and type 2 DM, 
polycystic ovary syndrome, 
and sleep apnea 
• Additonal evaluation 
for underlying diseases: 
endocrinopathy, 
genetic diseases, 
and CNS disease/injury 
• Lifestyle 
  modification 
• Lifestyle 
  modification 
• Treatment of 
   comorbidities 
 
Maintain lifestyle 
modification and 
treatment of 
comorbidities 
Consider additional 
treatment: 
• pharmacotherapy 
• surgery 
gradual weight loss 
abnormal 
continued weight gain for >6 months 
abnormal normal 
normal 
Fig. 1. Stepwise assessment and treatment strategies for overweight and 
obesity children and adolescents. BMI, body mass index; CNS, central 
nervous system; NAFLD, nonalcoholic fatty liver disease; DM, diabetes 
mellitus. 
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kg/week. If greater weight loss is noted, monitor the patient for 
causes of excessive weight loss. 
3) Adolescents aged 12–18 years
(1) BMI 85th–94th percentile (overweight)
The weight goal is weight maintenance until reaching a BMI not 
exceeding the 85th percentile or slowing of weight gain, as indicated 
by the downward deflection in the BMI curve. 
(2) BMI 95th–98th percentile (obesity)
The weight goal is weight loss until reaching a BMI below the 
85th percentile, with no more than an average of 0.9 kg/wk. If great-
er weight loss is noted, monitor the patient for causes of excessive 
weight loss. 
(3) BMI ≥99th percentile (severe obesity)
The weight goal is weight loss not exceeding the average of 0.9 
kg/wk. If greater weight loss is noted, monitor the patient for causes 
of excessive weight loss. Patients may warrant tertiary care evalu-
ation to determine the next level of treatment. 
2-2. We recommend a family-based, comprehensive, multi-
disciplinary team approach to succeed in behavioral interven-
tions (active vigorous physical activity and reduction of in-
activity, accompanied with calorie-controlled diet) for the 
treatment of obesity in children. (strength of evidence, I; grade 
of recommendation, A)
The interactions between parents and children and parenting 
styles strongly affect the unhealthy lifestyle habits of children.24) 
Obese children are more likely to be bullied and have fewer friends 
or are less popular among classmates compared with thinner peers.25) 
Parents, teachers, and friends have indicated that youths who 
are obese are easily isolated and have poorer social relationships 
compared with their counterparts.26) Those with low self-esteem and 
Table 2. Lists of obesity-related comorbidity and corresponding screening tests
Comorbidity Definition
NAFLD Alanine aminotransferase; ≥26 U/L (boys) and ≥22 U/L (girls)
Ultrasonography, if indicated
Prediabetes HbA1c of 5.7% to 6.5% (39 to 48 mmol/mol)
Fasting plasma glucose; 100–125 mg/dL (5.5–6.9 mmol/L)
Two-hour plasma glucose; 140–199 mg/dL (7.8–11.0 mmol/L)
Type 2 DM HbA1c ≥ 6.5% (≥48 mmol/mol)
Fasting plasma glucose; ≥126 mg/dL (≥7.0 mmol/L)
Two-hour plasma glucose; ≥200 mg/dL (≥11.1 mmol/L) during an oral glucose tolerance test
In a patient with classic symptoms of hyperglycemia, a random plasma glucose; ≥200 mg/dL
Dyslipidemia Fasting triglycerides (mg/dL) (multiply by 0.0113 to convert to mmol/L):
0–9 yr; <75 (acceptable), 75–99 (borderline high), ≥100 (high)
10–19 yr; <90 (acceptable), 90–129 (borderline high), ≥130 (high)
LDL cholesterol (mg/dL) (multiply by 0.0259 to convert to mmol/L): <110 (acceptable), 110–129 (borderline high), ≥130 (high)
Total cholesterol (mg/dL) (multiply by 0.0259 to convert to mmol/L): <170 (acceptable), 170–199 (borderline high), ≥200 (high)
HDL cholesterol (mg/dL) (multiply by 0.0259 to convert to mmol/L): <40 (low), 40–45 (borderline low), >45 (acceptable)
Non-HDL cholesterol (mg/dL) (multiply by 0.0259 to convert to mmol/L) (can be nonfasting): <120 (acceptable), 120–144 
(borderline high), ≥145 (high)
Prehypertension and  hypertension 3–11 yr: (standardized according to sex, age, and height percentile) 
BP of > 90th percentile to <95th percentile = prehypertension
BP of ≥ 95th percentile to <99th percentile + 5 mmHg = stage 1 HTN 
BP of ≥ 99th percentile + 5 mmHg = stage 2 HTN
12–17 yr: (standardized according to sex, age, and height percentile)
BP of >90th percentile to <95th percentile or > 120/80 mmHg = prehypertension
BP of ≥ 95th percentile to <99th percentile + 5 mmHg = stage 1 HTN
BP of ≥ 99th percentile + 5 mmHg = stage 2 HTN
PCOS Free and total testosterone and sex hormone binding protein
Ultrasonography, if indicated
Obstructive sleep apnea If there is a positive history, refer to a pulmonologist for nocturnal polysomnography and, if not available, overnight oximetry
Psychiatric problem If there is a positive history, refer to a mental health specialist.
NAFLD, non-alcoholic fatty liver disease; DM, diabetes mellitus; HbA1c, hemoglobin A1c; LDL, low-density lipoprotein; HDL, high-density lipoprotein; BP, blood 
pressure; HTN, hypertension; PCOS, polycystic ovary syndrome.
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higher BMIs are more likely to smoke and drink alcohol.27) These 
children are also less athletic and are not expected to have romantic 
relationships. Thus, they tend to demonstrate teasing, worsening 
of self-esteem, feeling of loneliness, depression, anxiety, and an 
introverted personality.28)
Data from 133 RCTs enrolling 30,445 patients through 16 sys-
temic reviews presented an evidence profile for each intervention, 
including medication, surgery, and lifestyle or community-based 
interventions, in overweight or obese children or adolescents. Phy-
sical activity interventions decrease systolic blood pressure (BP) 
and fasting glucose (low to moderate quality of evidence). Dietary 
interventions with low-carbohydrate diets have shown an effect in 
terms of BMI reduction (moderate quality of evidence). Educational 
interventions reduce waist circumference, BMI, and diastolic BP 
(low quality of evidence). Pharmacological interventions reduce 
BMI (metformin, sibutramine, and orlistat) and waist circumference 
(sibutramine and orlistat) as well as increase high-density lipoprotein 
cholesterol (sibutramine) but also raise systolic and diastolic BP 
(sibutramine). Surgical interventions (laparoscopic adjustable gastric 
banding, Roux-en-Y gastric bypass, and sleeve gastrectomy) have 
shown the largest BMI reduction (moderate quality of evidence). 
Combined interventions consisting of dietary modification, physical 
activity, behavioral therapy, and education significantly reduce 
systolic and diastolic BP, BMI, and triglycerides. Combined parent-
child and parent-only interventions have similar effects on BMI (low 
quality of evidence).29)
A school-based intervention reportedly reduces BP and body fat 
in young teenagers. Short-term cardiovascular health in children-
targeted interventions showed successful results in demonstrating 
affected physiological variables according to increased time spent 
in moderate to vigorous physical activity at school (20 minutes per 
day in elementary schools, 30 minutes in middle schools).30) Both 
school-designed workout and adult supervision in physical activities 
affected the amount of physical activity of sixth to eighth graders 
participating in their free time.31)
A systemic analysis of 24 reports reviewing 15 studies showed 
strong evidence that reduced screen time and enhanced physical 
activity could prevent obesity. Data from 11,000 preschool children 
4 to 6 years of age linked increased caloric intake from snacks and 
sugar-sweetened beverages with increased screen time.32) Another 
study revealed that decreasing screen time also decreases sedentary 
time.33) A 2-generation study associated increased BMI with 2 hours 
of screen time per day for both parents and offspring.34)
In a prospective cohort study in England of a family-based be-
havioral treatment in 33 families with severely obese children aged 
8 to 13 years, the families were advised to practice self-monitoring, 
keeping daily food and activity records, goal setting, positive rein­
forcement, and stimulus control to modify the child’s eating and 
exercise behaviors. Foods were categorized into “traffic light” food 
colors of red, yellow, and green foods; physical activity aspects were 
also advised. Severely obese children were reported to have lost 8.4% 
of BMI over 3 months, maintained at the 3-month follow-up. Self-
esteem and depression also improved significantly.35)
A study concerning the relationship between parenting style 
and development of obesity in children showed that authoritarian 
parenting is highly associated with the risk of being overweight 
among young children.24) 
Interviews performed in children with obesity and parents with 
obese children revealed that a lifestyle behavior improvement 
program benefits from parental support and needs help from family, 
peers, and friends.36) The studied children with obesity benefited from 
the persistent involvement of supportive persons in the maintenance 
of lifestyle behavior changes. The respondents expected to achieve 
weight reduction by physical activity or eating healthy meals. The 
parents reported struggling with adopting new rules and insufficient 
support from family members. Children reported suffering from 
inconsistent parenting and low support from their parents. Their 
experience of bullying at school was an obstacle to their ability to 
achieve the necessary changes. Support from peers stimulated their 
progress. Parents identified that the general practitioner is required 
to discuss overweight in a nonoffensive manner and to present in-
terest in the process of weight reduction. The general practitioner 
should play a more supportive role.36)
The Oklahoma Chapter of the American Academy of Pediatrics 
Obesity Committee developed a resource toolkit for pediatric pri-
mary care providers to be used in behavioral counseling of obese 
children. Eight topics were selected for the handouts: sugars-
sweetened beverages, daily screen time, sleep, proper breakfast, 
family mealtime, physical activity, balanced meals, and food 
quality. The resource toolkit sets four steps, utilizing motivational 
interviewing techniques, to assist with facilitating behavior change: 
(1) obtaining patient history, (2) discussing health habits and the 
family’s reasons for changing habits, (3) setting a realistic goal for 
change, and (4) realizing goals. This handout also provides a patient 
questionnaire on health habits to assist with the identification of 
behaviors to be changed, eight provider and parent handouts on 
healthy behaviors, and a motivational interviewing guide.37)
Behavioral interventions target lifestyle change (e.g., counseling 
on diet, increasing physical activity or decreasing sedentary beha-
vior, and addressing behavior change) to limit weight gain or de-
crease weight.38) Effective behavioral interventions include parental 
support and the delivery of basic instructive information on healthy 
nutrition and physical activity. Additional components of the most 
effective interventions include the following: (1) being conducted 
in a specialty setting; (2) targeting both children and their parents; 
(3) helping parents and children engage in stimulus control (e.g., 
limiting access to tempting foods and limiting screen time); and 
(4) assisting participants in identifying goals, self-monitoring, and 
problem solving to accomplish their selected goals. Other common 
components include contingent use of rewards or reinforcement, 
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motivational interviewing, teaching of coping skills, addressing body 
image, and the option of individual–family counseling to address 
family-specific issues. All of the effective studies have emphasized 
eating healthy foods and using moderate portions.
The distinguishing characteristics of comprehensive multidisci-
plinary interventions are increased intensity of behavioral change 
strategies, greater frequency of patient-provider contact, and in­
volvement of specialists in the treatment. Formalized behavioral 
therapy and a multidisciplinary treatment team exceed the capacity 
of the services most primary care providers can supply.
Systematic evaluation of body measurements, dietary intake, and 
physical activity should be conducted at baseline and at specific 
intervals throughout a program. For the implementation of a com-
prehensive multidisciplinary intervention, the comprehensive 
treatment should be provided by a multidisciplinary obesity care 
team, including a behavioral counselor (for example, social worker, 
psychologist, other mental health care provider, or trained nurse 
practitioner), registered dietitian, and exercise specialist (physical 
activity specialist or another team member with training or a 
community program prepared to assist children with obesity). 
2-3. We recommend that pharmacotherapy and bariatric surgery 
be considered only in patients with morbid obesity with major 
comorbidities after a formal program of intensive lifestyle mo-
dification has failed. (strength of evidence, V; grade of recom-
mendation, A based on committee voting)
Pharmacotherapy should only be performed in accordance 
with lifestyle modification.39) The prescription of weight-reducing 
medicines used off-label to adolescents under 16 years of age should 
be discouraged for the following reasons: (1) the lack of U.S. Food 
and Drug Administration (FDA) approval, (2) insufficient number 
of safety and efficacy studies performed in children and adolescents 
with obesity, (3) limited efficacy for most agents, and (4) the problem 
of drug-induced adverse reaction related with potential obesity-
related morbidity and mortality. For obese youth who are unable 
to achieve sufficient weight loss with lifestyle interventions alone, 
adjunctive use of more intensive treatments, including pharma-
cotherapy, may be appropriate. However, the search for obesity 
medications that are proved to be safe for long-term use, efficacious 
to promote sufficient weight reduction, and have a good risk–be-
nefit ratio remains fruitless. Nevertheless, there is great hope in the 
successful development of more effective, etiology-based anti-
obesity therapies for children and adults. 
FDA-approved pharmacotherapy for obesity should be admini-
stered only with a concomitant lifestyle modification program of 
the highest intensity available, and only by clinicians who are ex-
peri enced in the use of antiobesity agents and aware of their risk 
for adverse reactions.40) Medication should be discontinued, and the 
pati ent re-evaluated, if the reduction in BMI or BMI z score is less 
than 4% after antiobesity medication for 12 weeks at full dosage.11)
In adolescents with extreme obesity, clinicians may consider 
bariatric procedures if the patient shows poor response to medical 
treatment for weight loss. Indications for bariatric surgery include 
BMI of >35 kg/m2, accompanying comorbidities of obesity such 
as type 2 DM, moderate-to-extreme sleep apnea, pseudotumor 
cerebri, debilitating orthopedic problems, and nonalcoholic steato-
hepatitis with advanced fibrosis. Another candidate profile for 
bariatric surgery is a BMI of >40 kg/m2 with mild comorbidities 
(hypertension, dyslipidemia, moderate orthopedic problems, mild 
sleep apnea, nonalcoholic steatohepatitis, and extreme psycholo-
gical distress that is secondary to the obesity).41,42)
3. Behavioral intervention for children and adolescents with 
obesity: diet
3-1. We recommend the decrease in intake of sugar-sweetened 
beverages. (strength of evidence, I; grade of recommendation, A)
3-2. We recommend the reduction in total energy intake. (strength 
of evidence, I; grade of recommendation, A)
3-3. We suggest the use of small-sized plates or bowls. (strength of 
evidence, III; grade of recommendation, C)
3-4. We suggest the decrease in consumption of fast food. (strength 
of evidence, III; grade of recommendation, C)
3-1. We recommend the decrease in intake of sugar-sweetened 
beverages. (strength of evidence, I; grade of recommendation, 
A)
The Korean National Health and Nutrition Examination Survey 
performed between 2008 and 2011 revealed that the mean amount 
of daily sugar-sweetened beverage consumption was 98.7 mL/
day in school children, which tended to increase with age.43) This 
Korean study revealed that overweight and obesity are significantly 
associated with high sugar-sweetened beverage intake among boys 
aged 7–12 years (odds ratio, 1.72).43) A randomized trial performed 
in adolescents aged 13 to 18 years demonstrated that BMI changes 
are significant between a sugar-sweetened beverage restricted 
group and a control group among subjects in the upper-baseline 
BMI percentile.44) A more recent randomized trial that investigated 
the effects of an intervention designed to decrease consumption 
of sugar-sweetened beverages on weight gain showed significant 
differences in the BMI changes between the intervention group and 
control group at both 1 and 2 years among Hispanic adolescents.45) 
Similar to the results from studies in older children, sugar-sweeten-
ed beverage consumption has been positively associated with BMI 
z scores in children at 4 and 5 years in a large-scale, longitudinal 
cohort study.46) A recent systematic review revealed a significant 
positive association between sugar-sweetened beverage consump-
tion and total adiposity among children under 12 years old.47) A 
cross-sectional analysis of children’s dietary data reported that 
sugar-sweetened beverage intake is independently associated with 
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fast food intake and overweight and obesity.68) However, a recent 
large-scale observational study performed in Jeju Island revealed 
that obese children had significantly higher rates of fast food 
consumption.69) 
4. Behavioral intervention for children and adolescents with 
obesity: exercise
4-1. We recommend physical activity, which is beneficial to all 
children and adolescents. (strength of evidence, I; grade of re-
commendation, A)
4-2. We recommend moderate to vigorous levels of physical 
activity, including regular and steady exercise, which is helpful in 
promoting a decrease in weight. The recommended duration of 
moderate to vigorous exercise is at least 20 minutes, with a goal 
of 60 minutes, 5 days per week. (strength of evidence, I; grade of 
recommendation, A)
4-3. We recommend programmed exercises, which are helpful 
in reducing body fat in children and adolescents. (strength of 
evidence, I; grade of recommendation, A)
4-1. Physical activity is beneficial to all children and adolescents. 
(strength of evidence, I; grade of recommendation, A)
Physical activity is especially effective in enhancing cardio-
vascular fitness, decreasing body fat, and lowering risk factors 
for diabetes.70-73) Apart from the benefits for maintaining weight 
and reducing health risks related to childhood obesity, physical 
activity may prove to enhance aspects of children’s brain activation, 
including cognitive development.74,75) Therefore, the WHO, Ameri-
can Alliance for Health, Physical Education, Recreation and Dance, 
British Association of Sport and Exercise Medicine, and Canadian 
Academy of Sport and Exercise Medicine recommend for children 
to participate in physical activities as early as possible. Guidelines 
that recommend suitable physical activities for each age group have 
also been formulated in developed countries.
(1) Children and youth aged 5–17 years should accumulate at 
least 60 minutes of moderate- to vigorous-intensity physical activity 
daily.
(2) Physical activity greater than 60 minutes in duration provide 
more health benefits.
(3) Most of the daily physical activity should be aerobic. Vigorous-
intensity activities should be incorporated, including those that 
strengthen muscle and bone, and performed at least 3 times per 
week.
4-2. Moderate to vigorous levels of physical activity, including 
regular and steady exercise, are helpful in promoting a decrease 
in weight. (strength of evidence, I; grade of recommendation, A)
Regular exercises improve weight and BMI, as well as blood sugar 
and triglyceride levels.70,76-78) The degree of weight loss is maximized 
when exercise is combined with decreased calorie intake, which is 
alterations in lipid profiles, increased markers of inflammation, and 
increased waist circumference.48)
3-2. We recommend the reduction in total energy intake. (strength 
of evidence, I; grade of recommendation, A)
Current evidence suggests that weight status can be improved in 
overweight or obese children and adolescents by a reduced-energy 
diet. However, the association between weight improvement and 
macronutrient distribution of a reduced-energy diet is controversial 
in children and adolescents.49) 
In an adult systemic review, the overweight and obese population 
who consumed low glycemic index food lost more weight and 
showed better improvement in lipid profiles.50) A pediatric systematic 
review comparing low glycemic index/low glycemic load with high 
glycemic index/high glycemic load diets did not reveal the effect of 
weight loss; however, it reported decreases in serum triglyceride and 
HOMA (homeostasis model assessment) index.51) 
Meanwhile, studies on the association between eating quickly and 
overweight/obesity have showed conflicting results. Several cohort 
studies conducted in Japan have demonstrated that eating quickly is 
significantly associated with overweight in girls.52,53) A population-
based study conducted in Portugal reported no significant asso-
ciation between eating quickly and overweight/obesity.54) 
There is weak evidence regarding the association between 
breakfast intake and obesity.55-58) Likewise, current evidence does not 
show that the consumption of fruits and vegetable is associated with 
overweight and obesity in children and adolescents.59,60) In an adult 
study, energy density independently affects energy intake; however, 
data are lacking for children and adolescents.61)
3-3. We suggest the use of small-sized plates or bowls. (strength of 
evidence, III; grade of recommendation, C)
Systematic reviews in adults have consistently shown that energy 
intake increases with larger portion sizes.61) A recent systematic 
review showed that children also consistently consume more 
food and drink when offered larger-sized portions, packages, or 
tableware than when offered smaller-sized versions.62) Total calo-
rie consumption reportedly decreases in those receiving small 
portion sizes among children under 6 years of age.63,64) A recent 
observational study revealed that reduced portion sizes are asso-
ciated with BMI reduction after 1 and 2 years among children and 
adolescents.65)
3-4. We suggest the decrease in consumption of fast food. 
(strength of evidence, III; grade of recommendation, C)
The intake of fast food has an effect on overweight and obesity in 
school children and adolescents. Composition data from leading fast 
food company websites show that fast foods have very high energy 
density.66,67) A Korean nationwide observational study performed in 
2001 reported contrasting results regarding the association between 
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also helpful in sustaining improved weight after weight loss. The 
degree of weight loss is minimal in the absence of calorie intake 
restriction.
Moderate exercise refers to exercise that causes mild increases in 
breathing and heart rate.71,74) In other words, conversation is doable 
during moderate exercise, whereas singing is difficult to perform 
simultaneously. Brisk walking, cycling, and practice in such sports 
as soccer, basketball, and badminton, are examples of moderate 
exercise. Meanwhile, conversation is difficult and singing impossible 
during vigorous exercise, owing to significant increases in breathing 
and heart rate. Running fast, jump rope workout, inline skating, and 
playing a game of soccer, basketball, or badminton are examples 
of vigorous exercise. At least 20 minutes of moderate exercise is 
recommended, with a goal of 60 minutes, 5 days per week, whereas 
vigorous exercise is effective when done 3 times per week.75,79,80)
4-3. Programmed exercises are helpful in reducing body fat in 
children and adolescents. (strength of evidence, I; grade of 
recommendation, A)
The effect of exercise programs is maximized with the involve-
ment of a specialist to instruct the activity or when friends or family 
members participate in together.81-83) The type, frequency, intensity, 
and duration of exercises should be included in the prescription 
of the program. Moreover, prescriptions for resistance training 
programs should be individualized to stimulate all of the major 
muscle groups and use all of the muscle groups.72) 
In addition, exercise intensity should be adjusted stepwise ac-
cording to age and BMI, rather than engaging in high-level exercise 
from the beginning.14) Especially in patients with high-level obesity, 
weight-bearing exercise, such as excessive jump rope, should be 
avoided because repeated impact may be applied to parts such 
as knees, ankles, and hip joints (Table 3). However, according to 
a recent meta-analysis that investigated the impact of physical 
education on obesity prevention in children, adolescents, and adults, 
although physical education has positive effects on obesity-related 
body indices and health status, its effect is statistically insignificant. 
Moreover, there is lack of evidence based on data.72)
5. Behavioral intervention for children and adolescents with 
obesity: lifestyle
5-1. We recommend increasing physical activity and limiting 
sedentary time (nonacademic screen time, digital activities) to 1 
to 2 hours per day for weight reduction. (strength of evidence, I; 
grade of recommendation, A)
5-2. We recommend maintaining adequate sleep duration for the 
prevention of obesity in children and adolescents. (strength of 
evidence, I; grade of recommendation, A)
5-3. We recommend a family-centered approach, including 
parents, to prevent and treat children’s obesity effectively; parental 
obesogenic lifestyle habits are related to children’s obesity. (strength 
of evidence, I; grade of recommendation, A)
Table 3. Stepwise exercise strategies according to age and obesity status
Age group Obesity status First intervention step Advanced intervention step
Infant (<2 yr) Weight for height ≥ 95th percentile Prevention counselling Prevention counselling
Early childhood (2–5 yr) BMI 5th–84th percentile Prevention counselling Prevention counselling
BMI 85th–94th percentile with no risks
BMI 85th–94th percentile with risks Step 1 Step 2
BMI ≥95th percentile Step 1 Step 3
Middle childhood (6–11 yr) BMI 5th–84th percentile Prevention counselling Prevention counselling
BMI 85th–94th percentile with no risks
BMI 85th–94th percentile with risks Step 1 Step 2
BMI 95th–99th percentile Step 1 Step 3
BMI>99th percentile Step 1
Step 2 or 3, if family is motivated Step 4, if appropriate
Adolescence (12–18 yr) BMI 5th–84th percentile Prevention counselling Prevention counselling
BMI 85th–94th percentile with no risks
BMI 85th–94th percentile with risks Step 1 Step 2
BMI 95th–99th percentile Step 1
BMI >99th percentile Step 1 Step 4, if appropriate
Step 2 or 3 if patient and family are motivated
BMI, body mass index.
Step 1: Prevention plus management; be physically active ≥ 1 hour each day. Young children: unstructured play in young children. Older children: should find 
physical activities that they enjoy. Step 2: Structured weight management; Planned, supervised, physical activity or active play for 60 minutes per day. Step 3: Com-
prehensive multidisciplinary management; Physical activity goal setting, and contingency management. Negative energy balance resulting from structured physical 
activity changes is planned. Multidisciplinary team with experience in childhood obesity including exercise specialist. Step 4: Tertiary care management.
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5-4. We recommend the development of specific public health 
interventions as essential to overweight and obesity control in 
children with lower socioeconomic status (SES). (strength of 
evidence, I; grade of recommendation, A) 
5-5. We recommend that obesity interventions be conducted in 
multiple key childhood environments, including family, school, 
and community. (strength of evidence, I; grade of recom menda-
tion, A) 
5-1. We recommend increasing physical activity and limiting 
sedentary time (nonacademic screen time, digital activities) to 1 
to 2 hours per day for weight reduction. (strength of evidence, I; 
grade of recommendation, A)
Obese children tend to commute to school by school bus rather 
than walk to school.84-86) The sedentariness of obese children is 
higher than that in normally weighted children; the former have 
been shown to like to lie down when staying indoors and use the 
elevators more than stairs.84,87,88) Obese children spend a high pro-
portion of their day watching television or using the personal 
computer compared with normally weighted children.84,89-91) In-
creased television-viewing time decreases physical activity, and 
can increase the consumption of high-calorie diet through being 
exposed to television commercials of high-calorie foods, such as 
fast food, snack, and soft drinks.84,92-96) The effort to walk as much as 
possible and exercise regularly is significantly related to losing body 
weight.86)
5-2. We recommend maintaining adequate sleep duration for the 
prevention of obesity in children and adolescents. (strength of 
evidence, I; grade of recommendation, A)
A school-based, cross-sectional study of 3,785 Korean adolescents 
in middle and high school between the ages of 11 and 18 years 
showed the significant association of longer sleep duration on both 
week day and weekends with decreased BMI for both sexes.97) A 
study using data of 489 adolescents aged 12 to 18 years from the 
Korean National Health and Nutrition Examination Survey from 
2013 to 2014 showed that the risk of obesity decreases with in-
creased sleep duration.98) Researches in Canada, Japan, and China 
showed an inverse correlation between sleep duration and obesity in 
children.98-101)
Sleep restriction results in significant increases in caloric intake. 
102,103) Short sleep is associated with decreased moderate to vigorous 
physical activity and increased sedentary time.102,104) A significant 
negative association has been observed between sleep duration 
and screen time.102,105) Short sleep is also associated with insulin 
resistance.102) 
5-3. We recommend a family-centered approach, including pa-
rents, to prevent and treat children’s obesity effectively; parental 
obesogenic lifestyle habits are related to children’s obesity. 
(strength of evidence, I; grade of recommendation, A)
According to a meta-analysis conducted with studies published 
between 2000 and 2009, the majority of studies (70%) have shown 
statistically significant moderate to large effect size changes in child 
BMI after participation in a family-based intervention for weight 
loss. Of these, 50% reported statistically significant weight loss 
changes at 6-month, 1-year, and 2-year follow-up, albeit with small 
to moderate effect sizes.106)
In a study of Korean first-grade elementary school students and 
their parents, parental lifestyle habits were shown to induce child-
ren’s obesity.107) Children of obese parents are more likely to be 
diagnosed as overweight compared with children of normal-weight 
parents. Among the paternal lifestyle habits, hours of watching 
television or computer usage, and consumption frequency of 
soda, ice cream, cake, and chips are related to the children being 
overweight. Among the maternal lifestyle habits, hours of watching 
television or computer usage, frequency of eating breakfast, and 
frequency of overeating are related to the children being overweight. 
Parents’ lifestyle habits can affect children’s weight via an effect on 
the children’s lifestyle habits. The degree of obesity between parents 
and children tends to be similar because parents and children share 
not only genes but also the same family environment. Family 
environment plays an important role in forming children’s lifestyle, 
including eating habits and physical activity through parents’ life-
styles. As the mother tends to take the main role in rearing children, 
maternal obesogenic lifestyles have greater influence on children’s 
obesity.
5-4. We recommend the development of specific public health 
interventions as essential for overweight and obesity control 
in children with lower SES. (strength of evidence, I; grade of 
recommendation, A)
According to a study based on data of the Korea National Health 
and Nutrition Examination Survey 2007–2010 conducted by the 
Korea Centers for Disease Control and Prevention, SES does not 
affect the observed relationships of overweight or obesity in child ren 
aged 2–18 years.108) However, recent published systematic reviews 
and meta-analyses have showed that children with lower SES have 
higher risks of being diagnosed with overweight and obesity.109,110) 
Another systematic review and meta-analysis of studies published 
between 1990 and 2014 showed that low SES is associated with a 
10% higher risk of overweight and a 41% higher risk of obesity in 
children aged 0–15 years.109) In a subgroup analysis, this relation ship 
was prominent in high-income countries and in more economic 
developed areas, including North America, Europe, and Oceania.109) 
Another systematic review to describe the relationship between SES 
and childhood/adolescent weight status in papers published in rich 
countries from 1990 through 2013 showed a predominantly inverse 
relationship.110)
Adolescents from areas with low SES more often skipped break-
fast and more often ate snacks compared with adolescents from 
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high SES areas.111,112) SES has been positively associated with food 
frequency intake scores in both sexes. Adolescents with low SES 
tended to show an irregular meal pattern.31,33) High household SES 
is also associated with increased intakes of vegetables, fruits, and 
dietary fiber, and with decreased intakes of fat.111,113,114)
A study on the association among parental socioeconomic level, 
overweight, and eating habits with diet quality in Korean sixth-
grade school children showed that a lower SES (in terms of parental 
income or parental education level) relates to the consumption of 
significantly fewer fruits.111) In the same study, the children in the 
lower socioeconomic group had a lower food habit score (high 
frequency of breakfast skipping and ramen noodle consumption), 
diet quality, and intake of nutrients compared with those in the 
higher socioeconomic group. Lower maternal education status 
is also associated with a higher risk for being overweight in girls. 
Specific public health interventions should support parents and 
children with lower SES to develop health-related behaviors that 
may prevent childhood obesity. 
5-5. We recommend that obesity interventions be conducted in 
multiple key childhood environments, including the family, 
school, and community. (strength of evidence, I; grade of re-
commendation, A)
Most strategies for preventing or reducing childhood obesity 
have focused on individual behavior modification with limited 
success.115,116) The environment of children with obesity, including 
family, schools, after-school programs, and community, as well 
as the policy level, can be changed to promote healthier lifestyles 
through multilevel obesity interventions.115,117) The family repre-
sents the closest environment of children; thus, the family is im-
portant to forming the healthy lifestyle of children.115,107) School is 
the place where students spend most of their time beginning with 
the time they reach schooling age.115,118) Children can maintain and 
manage a healthy lifestyle through teacher–pupil interaction and 
peer interaction.115,118) In the treatment or prevention of childhood 
obesity, a variety of support systems through parents, peers, and 
teacher relationships can induce changes in the overall environment 
surrounding children, thereby raising the effectiveness of any obe-
sity intervention.115) Multidisciplinary interventions can make obese 
children continue a healthy lifestyle.115) Obesity in children and 
adolescents is linked to adult obesity and various diseases, leading to 
an increase in public medical expenses. Therefore, national policy is 
needed in leading efforts to preventing obesity fundamentally and 
to establishing education and policy for health promotion.
6. Behavioral intervention for children and adolescents with 
obesity: mental health
6-1. We recommend that obese children be monitored for psy-
chological problems and screened for the need for psychiatric 
treatment. (strength of evidence, I; grade of recommendation, A). 
6-2. We recommend that physicians emphasize family functioning 
and let the family participate in the treatment of the obese child. 
(strength of evidence, I; grade of recommendation, A). 
6-3. We recommend cognitive behavioral therapy, which may be 
beneficial to treating child obesity. (strength of evidence, III; grade 
of recommendation, C)
6-1. We recommend that obese children be monitored for psy-
chological problems and screened for the need for psychiatric 
treatment. (strength of evidence, I; grade of recommendation, A)
Obese children may be suffering from low self-esteem, body 
shape dissatisfaction, depression, eating disorder, obesity stig-
ma, teasing, or bullying by peers.119-125) They also live with signi-
ficantly lower health-related quality of life compared with normal 
weighing children, or several pediatric chronic diseases.126) Obese 
children complain of a low quality of life associated with physical 
and psychosocial health, and emotional, social, and school func-
tioning.126,127) 
Extremely obese adolescents have higher rates of mood, anxiety, 
somatoform, and eating disorders compared with a population-
based control group.128) The screening tools for psychological 
problems include the Korean-Child Behavior Checklist, Children’s 
Depression Inventory, Korean version of the Eating Attitude 
Test-26, somatotype drawings, and Pediatric Quality of Life In-
ventory.121-123,126-127)
6-2. We recommend that physicians emphasize family function-
ing and let the family participate in the treatment of the obese 
child. (strength of evidence, I; grade of recommendation, A)
Poor family functioning is associated with increased risk of 
obesity and overweight.129,130) The elements of poor family func-
tioning related to obesity are poor communication, poor behavior 
control, high levels of family conflict, and low family hierarchy 
values.130) Although standardized family functioning measures 
are necessary, half of the identified intervention studies reported a 
significant relationship between family functioning and changes 
in child weight.130) Contrary to these reports, several studies have 
reported that family functioning is not associated with child obesity; 
rather, an overweight mother is largely linked to child obesity.131,132) 
Given the high correlation of parental or mother’s obesity with 
child obesity, parental behavior changes in the family should be 
considered.132,133) Family-based treatment is crucial to control nip 
successfully child obesity.
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6-3. We suggest cognitive behavioral therapy, which might be 
beneficial to treating child obesity. (strength of evidence, III; 
grade of recommendation, C)
Cognitive behavioral therapy (CBT) is effective in treating 
childhood obesity.134-136) The treatment goal is weight control by 
healthy changes in lifestyle rather than weight reduction. The key 
element of this therapy is self-regulation, with techniques including 
learning self-instructions (e.g., “stop and think”), self-observation, 
self-evaluation, and self-reward.136) To train self-regulation skills, 
modeling (showing the coping skills to the child), behavior rehearsal, 
and homework have been used.136) Coping skills are taught for 
different stressful situations (e.g., feeling alone) and relapse moments 
(e.g., feeling hungry).134,135) The progression of CBT is concentrated 
on one new small change in food and exercise behavior (e.g., 
drinking water instead of soft drinks, walking instead of taking the 
car).135,136) Self-monitoring—recording one’s behavior—is perhaps the 
most important component of behavioral treatment. Patients keep 
detailed records of their food intake, physical activity, and body 
weight, which they review with their interventionist to identify areas 
of success and for improvement.137)
Parents participate in CBT as helpers. For the stimulus control of 
the obese child, parents are taught the importance of ending restric-
tions on the places and times for eating. Motivation of the obese 
child is enhanced by allowing his or her own choices in planning 
the program and using a child-friendly approach with respect to 
developmental demands; for example, providing activities involving 
cooking, moving, and playing.134,135) Braet et al.135) reported that in 
the long-term follow-up over 4.6 years, 71.6% subjects treated with 
CBT showed no further increase in percentage overweight.
Negative body image is a major concern of overweight persons. 
CBT includes the information to change negative stereotypes of 
obesity, modification of intrusive thoughts of body dissatisfaction 
and overvalued beliefs regarding physical appearance, exposure to 
avoided body image situations, and elimination of body checking. 
CBT has significantly improved the body image, psychological 
symptoms, self-esteem, overeating, and guilt eating in obese 
subjects.138)
7. Pharmacotherapy of children and adolescents with obesity
7-1. We recommend that pharmacologic treatment is not used as 
a primary treatment nor sole therapy mode in pediatric obesity. 
(strength of evidence, I; grade of recommendation, A)
7-2. We recommend that the response and adverse reaction to 
pharmacologic treatment be monitored closely. The decision 
to continue or discontinue should be made by accounting for 
the monitoring result. (strength of evidence, V; grade of recom-
mendation, A, based on committee voting)
7-1. We recommend that pharmacologic treatment not be used 
as a primary treatment nor lone therapy method in pediatric 
obesity. (strength of evidence, I; grade of recommendation, A)
Only a few studies have been conducted in pharmacologic treat-
ment for childhood obesity. In a prepubertal age group (younger 
than 12 years old), the effectiveness and safety of pharmacologic 
treatment of obesity are low because of issues of appropriate dos age, 
safety, adverse event, and ethical aspects.139,140) Research data on 
adolescents over the age of 12 years are not sufficiently accumulated 
as well. However, some weight loss effects could be expected.139-141) 
Therefore, in case of primary treatment failure, an approved drug 
could be considered added, along with behavioral intervention.
Orlistat, metformin, glucagon-like peptide 1 (GLP-1) agonists, 
and topiramate are available in adult obesity, and there have been 
a considerable number of efforts to use these agents in childhood 
obesity.142-146) Orlistat is the only drug that the FDA has approved 
for childhood obesity over the age of 12 years, but it is not recom-
mended to use as a primary nor single therapy.141,147) Data on the 
single drug use of orlistat without behavioral therapy are not av-
ailable. In case of concerns on side effects, only behavioral therapy 
is recommended, instead of adding drugs.
1) Orlistat
Orlistat, a fat absorption inhibitor, is the only agent that the 
Korea Food and Drug Administration had approved for long-term 
use (one year) for weight control in pediatric obesity.148) It is the 
only FDA-approved drug that can be prescribed 3 times a day for 
childhood obesity in children aged 12 to 16 years.142,147) However, 
it is not recommended as a primary treatment for weight control 
in childhood obesity, especially between the ages of 2 and 11 
years.140,149) Orlistat inhibits lipid digestion by the suppression of 
pancreatic and gastric lipase. The decreased lipase activity in the 
gastrointestinal tract hinders consumed fat to be absorbed as a form 
of fatty acids and monoglycerols. Fat thus remains in the stool in 
triglyceride form.150) A placebo controlled study of obese children 
aged 12 to 16 years showed a significant reduction in BMI compared 
with the controls, but also reported significant side effects. Another 
study among obese teenagers aged 14 to 18 years failed to show 
significant weight loss.151)
Orlistat should be taken with meals, which makes it difficult to 
prescribe to school-aged children. In some reports, orlistat interferes 
with the absorption of fat-soluble vitamins, such as vitamins E and 
D.141) For many obesity-control drugs proven safe and effective 
for long-term use in adults, pediatric data are limited. Orlistat may 
cause adverse effects, such as steatorrhea, soiling, bloating, and 
increased number of bowel movement. Such adverse events have 
been reported in pediatric use. Younger patients are recommended 
to take multivitamins because orlistat can hinder the absorption of 
fat-soluble vitamins, such as vitamins A, K, and β-carotene. There 
have also been rare reports of hepatic and renal damage in adults, 
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and of oxalate nephrolithiasis and oxalate nephropathy with renal 
failure.152) 
2) Metformin
Metformin can be used safely in type 2 DM children over the age 
of 10 years and has been known to result in weight loss. It can be 
used at about 1,500 mg a day in children with type 2 DM between 
the ages of 12 to 14 years with BMI of 26–40 kg/m2.153) Although 
metformin can be used by type 2 DM children, it is not recom-
mended as treatment for only obesity; indeed, it has not been FDA 
approved as an obesity treatment.154-156) Metformin reduces hepatic 
glucose production, increases peripheral insulin sensitivity, and 
lowers appetite.157)
A study has shown BMI reduction after 6 to 12 months of use 
of metformin. A previous study reported that metformin has some 
effects in children with insulin resistance.158) Although metformin 
could be used in the short term, along with behavioral therapy, it is 
not recommended as a single drug for obesity treatment because of 
the limited effect of weight control.159)
3) Liraglutide
Liraglutide is a GLP 1 analog that can be used for long-term 
treatment of adult obesity.159) GLP-1 is the incretin hormone released 
by the ileal L-cells after food consumption, inducing satiety by 
delaying gastric emptying and glucagon secretion. It also controls 
appetite and satiety in the hypothalamus.141,149) In adult type 2 DM, 
GLP-1 is an effective primary therapy for controlling hemoglobin 
A1c (HbA1c) and weight. For obesity in adolescents, a significant 
decrease in BMI has been observed after 3 months of use.11,142) 
Liraglutide needs to be injected daily, which can be a limitation 
in pediatric application. Safety and pharmacokinetics have been 
tested in children with type 2 DM aged between 10 and 17 years: it 
has similar effects as in adults. However, about half of the subjects 
experienced at least one side effect.159) Among GLP-1’s side effects 
are nausea, vomiting, diarrhea, and low blood glucoses. However, 
rare but serious side effects have also been reported, such as kidney 
failure, suicidal impulse, pancreatitis, and gallbladder disease.152) 
Therefore, it is not recommended to use liraglutide for childhood 
obesity treatment.
4) Topiramate
Topiramate is a gamma-aminobutyric acid receptor antagonist 
that is known to be a treatment for epilepsy (for those aged 2 years 
and older) and migraine (for those aged 12 years and older). The 
weight loss effect of zonisamide (voltage-dependent sodium chan-
nels and T-type calcium blocker) was observed in the study of 
epilepsy, which might be related with the serotonin effect.141,152-153) 
Despite the weight control effect of topiramate and zonisamide, the 
findings of epilepsy studies cannot be directly generalized into sim-
ple treatment for childhood obesity.149)
No proven safety or efficacy data are available with combined 
therapy of phentermine-topiramate in pediatric obesity.152) The effect 
of zonisamide in pediatric obesity was reported in case reports of 
limited subjects.153) Headache, nausea, vomiting, thirst, decreased 
appetite, abdominal pain, anxiety, speech disorders, attention and 
memory deficit, somnolence, and diarrhea have been associated 
with topiramate and zonisamide.143-144,146) Serious side effects were 
reported in children using topiramate, such as glaucoma, stroke, 
metabolic acidosis, cognitive disorders, hyperammonianemia, 
encephalopathy, and kidney stone.152) Therefore, it is not recom-
mended to use topiramate for the treatment of childhood obesity.
7-2. We recommend that the response and adverse reaction of 
pharmacologic treatment be monitored closely. The decision 
to continue or discontinue treatment should be made with 
consideration for the monitoring result. (strength of evidence, V; 
grade of recommendation, A, based on committee voting)
Although cumulative data on the effectiveness of pharmacologic 
treatment of childhood obesity are insufficient, reports of adverse 
reactions related to those agents exist in many references, including 
adults’ studies.11,141,150,152,160) Therefore, pharmacologic treatment of 
childhood obesity should be taken cautiously, and careful obser-
vation and evaluation of its adverse reactions and effects are es­
sential.
8. Bariatric surgery for children and adolescents with obesity
8-1. We recommend that bariatric surgery be an appropriate 
option to improve health when adolescents with a BMI >40 kg/
m2 or >35 kg/m2 and obesity-related comorbidities fail to respond 
to behavioral interventions (with or without pharmacotherapy) 
for sufficient weight loss to achieve targeted health outcome goals 
and when they attain Tanner IV or V pubertal development and 
final or near-final adult height. (strength of evidence, V; grade of 
recommendation, A, based on committee voting)
The timing for surgical treatment of extremely obese adolescents 
remains controversial and depends, in most cases, on the compelling 
health needs of the patient.82) Physiologic maturation is generally 
complete by sexual maturation (Tanner) stage IV. Bariatric surgery 
is considered only under the following conditions: when the patient 
has attained Tanner IV or V pubertal development and final or near-
final adult height, BMI >35 kg/m2 with major comorbidities (type 
2 DM, moderate to severe sleep apnea of apnea-hypotonia index 
>15, pseudotumor cerebri, and severe nonalcoholic steatohepatitis) 
or BMI >40 kg/m2 with other comorbidities (hypertension, insulin 
resistance, glucose intolerance, dyslipidemia, sleep apnea with 
apnea-hypopnea index >5, and substantially impaired quality of 
life or activities of daily living). Skeletal maturation (adult stature) 
is normally attained by the age of 13 to 14 years in girls and 15 to 
16 years in boys. If uncertainty exists on whether adult stature has 
been attained, skeletal maturation (bone age) can be objectively 
https://doi.org/10.3345/kjp.2018.07360    
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